The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Introduction. TCMI with the effect of Liqihuoxue and Yiqihuoxue has been applied as complementary therapies during the perioperative period of PCI for patients with ACS, while the recommended time points and plans of TCMI are still short of the support of evidence-based medicine. Methods. A systemat...

Full description

Bibliographic Details
Main Authors: Zhaofeng Shi, Chen Zhao, Jiayuan Hu, Qianqian Dai, Manke Guan, Changming Zhong, Guihua Tian, Hongcai Shang
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2020/3834128
id doaj-4b9988ea6f0d42228e80291113d6f007
record_format Article
spelling doaj-4b9988ea6f0d42228e80291113d6f0072020-11-25T03:26:41ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882020-01-01202010.1155/2020/38341283834128The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsZhaofeng Shi0Chen Zhao1Jiayuan Hu2Qianqian Dai3Manke Guan4Changming Zhong5Guihua Tian6Hongcai Shang7Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing 100700, ChinaIntroduction. TCMI with the effect of Liqihuoxue and Yiqihuoxue has been applied as complementary therapies during the perioperative period of PCI for patients with ACS, while the recommended time points and plans of TCMI are still short of the support of evidence-based medicine. Methods. A systematic review and meta-analysis was conducted to evaluate the clinical efficacy and safety of TCMI on patients with ACS during the perioperative period of PCI. RCTs were searched based on standardized searching rules in seven medical databases from the inception up to August 2019. Two reviewers conducted the study selection, data extraction, and quality analysis independently. Data were analysed with the support of software RevMan and Stata. Results. A total of 68 articles with 6,043 patients were enrolled. The result of meta-analysis showed that the TCMI combined with western medicine was superior to the western medicine alone on clinical efficiency (before the PCI, before and after the PCI, or overall, P<0.05), the occurrence of MACE (myocardial infarction and stenocardia: before the PCI, before and after the PCI, or overall, P<0.05; arrhythmia: before and after the PCI, P<0.05), and the level of inflammatory factors (hs-CRP: before the PCI, before and after the PCI, or overall, P<0.05; IL-6: after the PCI, P<0.05). The TCMI with the effect of Liqihuoxue obtained more support compared with Yiqihuoxue based on the result of meta-analysis. Conclusions. TCMI with the effect of Liqihuoxue or Yiqihuoxue combined with western medicine generally showed the potential advantage on the treatment of ACS during the perioperative period of PCI. However, the optimal time point of intervention and recommended plan based on the effect still needs more clinical evidence. We consider that the research of precise and standardized application of TCMI will be a promising direction for TCM in the future.http://dx.doi.org/10.1155/2020/3834128
collection DOAJ
language English
format Article
sources DOAJ
author Zhaofeng Shi
Chen Zhao
Jiayuan Hu
Qianqian Dai
Manke Guan
Changming Zhong
Guihua Tian
Hongcai Shang
spellingShingle Zhaofeng Shi
Chen Zhao
Jiayuan Hu
Qianqian Dai
Manke Guan
Changming Zhong
Guihua Tian
Hongcai Shang
The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Evidence-Based Complementary and Alternative Medicine
author_facet Zhaofeng Shi
Chen Zhao
Jiayuan Hu
Qianqian Dai
Manke Guan
Changming Zhong
Guihua Tian
Hongcai Shang
author_sort Zhaofeng Shi
title The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_short The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_full The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_fullStr The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_sort application of traditional chinese medicine injection on patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2020-01-01
description Introduction. TCMI with the effect of Liqihuoxue and Yiqihuoxue has been applied as complementary therapies during the perioperative period of PCI for patients with ACS, while the recommended time points and plans of TCMI are still short of the support of evidence-based medicine. Methods. A systematic review and meta-analysis was conducted to evaluate the clinical efficacy and safety of TCMI on patients with ACS during the perioperative period of PCI. RCTs were searched based on standardized searching rules in seven medical databases from the inception up to August 2019. Two reviewers conducted the study selection, data extraction, and quality analysis independently. Data were analysed with the support of software RevMan and Stata. Results. A total of 68 articles with 6,043 patients were enrolled. The result of meta-analysis showed that the TCMI combined with western medicine was superior to the western medicine alone on clinical efficiency (before the PCI, before and after the PCI, or overall, P<0.05), the occurrence of MACE (myocardial infarction and stenocardia: before the PCI, before and after the PCI, or overall, P<0.05; arrhythmia: before and after the PCI, P<0.05), and the level of inflammatory factors (hs-CRP: before the PCI, before and after the PCI, or overall, P<0.05; IL-6: after the PCI, P<0.05). The TCMI with the effect of Liqihuoxue obtained more support compared with Yiqihuoxue based on the result of meta-analysis. Conclusions. TCMI with the effect of Liqihuoxue or Yiqihuoxue combined with western medicine generally showed the potential advantage on the treatment of ACS during the perioperative period of PCI. However, the optimal time point of intervention and recommended plan based on the effect still needs more clinical evidence. We consider that the research of precise and standardized application of TCMI will be a promising direction for TCM in the future.
url http://dx.doi.org/10.1155/2020/3834128
work_keys_str_mv AT zhaofengshi theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT chenzhao theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT jiayuanhu theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT qianqiandai theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT mankeguan theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT changmingzhong theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT guihuatian theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hongcaishang theapplicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhaofengshi applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT chenzhao applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT jiayuanhu applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT qianqiandai applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT mankeguan applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT changmingzhong applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT guihuatian applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hongcaishang applicationoftraditionalchinesemedicineinjectiononpatientswithacutecoronarysyndromeduringtheperioperativeperiodofpercutaneouscoronaryinterventionasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
_version_ 1715213099760353280